Melrose, MA, United States of America

Deborah Daly

This inventor holds 1 USPTO granted patent. Top assignee: Cambridge Neuroscience, Inc.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah Daly. Retrieved from https://idiyas.com/inventor/deborah-daly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Deborah Daly

Introduction

Deborah Daly is a notable inventor based in Melrose, MA (US). She has made significant contributions to the field of neuroscience through her innovative work. Her research focuses on calcium channel antagonists, which play a crucial role in various physiological processes.

Latest Patents

Deborah Daly holds a patent for "Calcium channel antagonists and methodology for their identification." This patent describes a substantially pure compound with a specific formula, which includes various chemical groups that can be independently selected. This innovation has the potential to impact the development of new therapeutic agents.

Career Highlights

Daly's career is marked by her dedication to advancing scientific knowledge and her commitment to research. She is associated with Cambridge Neuroscience, Inc., where she continues to explore the complexities of calcium channels and their implications in neuroscience.

Collaborations

Throughout her career, Deborah has collaborated with esteemed colleagues, including Stanley M Goldin and Kazumi Kobayashi. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Deborah Daly's work exemplifies the spirit of innovation in the field of neuroscience. Her contributions through her patent and collaborations highlight her commitment to advancing scientific understanding and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…